Clinical Trial Update: Ketamine Infusion for Adolescent Depression and Anxiety [Phase 4]

View source ↗

Summary

Phase 4 trial update on ketamine infusion for adolescents with major depressive disorder and anxiety disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Yale University | Conditions: Major Depressive Disorder, Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2020-03-16